Related Experiment Videos
Mesangiolytic glomerulopathy in a bone marrow allograft recipient
S S Iskandar1, M C Browning, W B Lorentz
1Department of Pathology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27103.
Human Pathology
|March 1, 1989
Summary
A boy developed kidney problems after a bone marrow transplant without Cyclosporine A. Renal biopsy showed diffuse mesangiolysis and glomerular sclerosis, suggesting a link between transplant conditioning and kidney damage.
Area of Science:
- Nephrology
- Hematology
- Oncology
Background:
- Bone marrow transplantation is a critical treatment for hematologic malignancies.
- Conditioning regimens often involve chemotherapy and total body irradiation.
- Immunosuppression, typically with agents like Cyclosporine A, is standard post-transplant care.
Observation:
- A pediatric patient with null-cell leukemia underwent bone marrow allograft.
- The patient did not receive Cyclosporine A post-transplantation.
- Unexplained deterioration of renal function was noted six months after the procedure.
Findings:
- Renal biopsy revealed significant pathological changes.
- Diffuse mesangiolysis and glomerular sclerosis were the primary findings.
- These findings indicate severe kidney damage potentially linked to the transplant protocol.
Implications:
- The absence of Cyclosporine A may be associated with post-transplant renal complications.
- This case highlights the importance of monitoring renal function after allogeneic transplantation.
- Further research is needed to understand the specific mechanisms and risk factors for transplant-related nephrotoxicity.